Neuralytix, LLC
USPTO PatentsView assignee record - 8 granted patents across 3 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Neuralytix ranks #32,610 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 3 technology areas.
- #32,610
- of 49,997 US assignees by volume
- Top 29%
- by Innovation Score (43.0/100)
- 15.5
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R32610 · US Corporation #32,610 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 8 grants
- MID-PACK #32,610/49,997
- PHOTO-FINISH Neomed Institute
- CPC-NARROW A61B · 3 areas
- INNOV-PAR 43.0/100
- CLAIMS-RICH 15.5 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2023–2025 · 3y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Neomed Institute (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Neuralytix’s 43.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Neuralytix
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Neuralytix · this assignee
Neuralytix · this assignee
43 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Neuralytix's Innovation Score is 43.0/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Neuralytix?
Each dot is one of Neuralytix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neuralytix’s own 15.5 claims/patent is at or below the 19.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Neuralytix's grants concentrate
Neuralytix, LLC is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Neuralytix sits between Neomed Institute and Neurostim Solutions, LLC.
Neuralytix's three-year grant acceleration
Neuralytix, LLC shows 4 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Neuralytix's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Neomed Institute
Neomed Institute
8 patents
- Neonatal Product…
Neonatal Product Group, Inc.
8 patents
- Neos Therapeutics
Neos Therapeutics, LP
8 patents
- Neureality
NeuReality Ltd.
8 patents
- Neuroenterprises
NeuroEnterprises, LLC
8 patents
- Neurovasc
NeuroVasc Technologies, Inc.
8 patents
- Neuroenhancement…
Neuroenhancement Lab, LLC
8 patents
- Neurostim Solutio…
Neurostim Solutions, LLC
8 patents
- Neuralytix ◀
Neuralytix, LLC
8 patents
What this shows Neuralytix holds 8 patents at rank #32,657, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Neuralytix
By rank, the assignees closest to #32,657 in granted patent volume.
- Neomed Institute #32,653 · 8 patents
- Neonatal Product Group, Inc. #32,654 · 8 patents
- Neos Therapeutics, LP #32,655 · 8 patents
- NeuReality Ltd. #32,656 · 8 patents
- NeuroEnterprises, LLC #32,658 · 8 patents
- NeuroVasc Technologies, Inc. #32,659 · 8 patents
- Neuroenhancement Lab, LLC #32,660 · 8 patents
- Neurostim Solutions, LLC #32,661 · 8 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Neuralytix's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Neuralytix's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 2 | 25.0% |
| 2024 | 2 | 25.0% |
| 2025partial year | 4 | 50.0% |
Which technologies does Neuralytix, LLC patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Neuralytix, LLC's patent record in context - here's where to go next.
- Neuralytix, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #32,610 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Neuralytix, LLC against Neomed Institute, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 43.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.